Epstein-Barr virus DNA change level combined with tumor volume reduction ratio after inductive chemotherapy as a better prognostic predictor in locally advanced nasopharyngeal carcinoma.

Zhong-Zheng XiangTao HeYuan-Yuan ZengFang LiuBian-Fei ShaoTian YangJia-Chun MaXi-Ran WangSi-Ting YuLei Liu

Published in: Cancer medicine (2022)

The new-developed indicator (EBVCL+TVRR) could better predict the LANPC patient's survival after IC compared with TNM stage system or RECIST 1.1 criteria.

Keyphrases

epstein barr virus
locally advanced
rectal cancer
neoadjuvant chemotherapy
diffuse large b cell lymphoma
squamous cell carcinoma
radiation therapy
phase ii study
circulating tumor
case report
cell free
single molecule
clinical trial
nucleic acid
open label